| Name | bevantolol |
|---|---|
| Synonyms |
(±)-1-[(3,4-Dimethoxyphenethyl)amino]-3-(m-tolyloxy)-2-propanol
(±)-1-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol 2-Propanol, 1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)- Bevantolol [INN:BAN] 1-[2-(3,4-dimethoxyphenyl)-ethylamino]-3-(3-methyl-phenoxy)-2-propanol 1-[2-(3,4-Dimethoxyphenyl)ethylamino]-3-m-tolyloxy-propan-2-ol bevantololum [INN_la] 1-{[2-(3,4-Dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol 1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol Bevantololum [INN-Latin] CI 775 Bevantololum BEVANTOLOL 1-{[2-(3,4-Dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)-2-propanol l-(3-methylphenoxy)-3-((2-(3,4-dimethoxyphenyl)-ethyl)-amino)-2-propanol 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol |
| Description | Bevantolol is a selective β-1 adrenoceptor antagonist. Bevantolol can be used for the research of angina pectoris and hypertension[1]. |
|---|---|
| Related Catalog | |
| Target |
Beta-1 adrenergic receptor |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 518.3±50.0 °C at 760 mmHg |
| Molecular Formula | C20H27NO4 |
| Molecular Weight | 345.433 |
| Flash Point | 267.3±30.1 °C |
| Exact Mass | 345.194000 |
| PSA | 59.95000 |
| LogP | 3.38 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.551 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| HS Code | 2922299090 |
|---|
|
~%
59170-23-9 |
| Literature: US4994618 A1, ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2922299090 |
|---|---|
| Summary | 2922299090. other amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |